GREAT POINT PARTNERS LLC - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 161 filers reported holding CYTOKINETICS INC in Q2 2020. The put-call ratio across all filers is 1.54 and the average weighting 0.3%.

Quarter-by-quarter ownership
GREAT POINT PARTNERS LLC ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$17,676,000
-9.7%
600,0000.0%3.22%
-16.0%
Q2 2023$19,572,000
+11.2%
600,000
+20.0%
3.83%
+10.9%
Q1 2023$17,595,000
-26.6%
500,000
-18.0%
3.46%
-39.9%
Q2 2022$23,967,000
+0.2%
610,000
-6.2%
5.75%
-0.6%
Q1 2022$23,927,000
+50.0%
650,000
+85.7%
5.78%
+63.2%
Q4 2021$15,953,000
+14.0%
350,000
-10.6%
3.54%
+8.8%
Q3 2021$13,990,000
-76.9%
391,429
-86.0%
3.26%
-40.3%
Q3 2020$60,674,000
+69.3%
2,802,525
+84.3%
5.46%
+90.5%
Q2 2020$35,841,000
+357.7%
1,520,635
+129.0%
2.86%
+250.2%
Q1 2020$7,830,000
+361.1%
664,097
+314.9%
0.82%
+452.7%
Q4 2019$1,698,000
-91.5%
160,073
-95.0%
0.15%
-94.2%
Q4 2018$20,055,000
-6.6%
3,173,288
+45.6%
2.54%
-24.2%
Q3 2018$21,470,000
+79.1%
2,179,688
+50.9%
3.35%
+101.3%
Q2 2018$11,989,000
+973.3%
1,444,481
+1252.5%
1.66%
+254.4%
Q4 2015$1,117,000
-62.7%
106,800
-66.1%
0.47%
-70.0%
Q1 2014$2,993,000315,0001.56%
Other shareholders
CYTOKINETICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 223,382$6,580,8347.72%
Finepoint Capital LP 431,693$12,717,6766.33%
Saturn V Capital Management LP 495,168$14,587,6496.11%
Logos Global Management LP 1,250,000$36,825,0004.91%
DAFNA Capital Management LLC 479,538$14,127,1894.39%
PFM Health Sciences, LP 2,399,545$70,690,5963.33%
Boxer Capital, LLC 2,100,000$61,866,0003.29%
Integral Health Asset Management, LLC 800,000$23,568,0003.26%
GREAT POINT PARTNERS LLC 600,000$17,676,0003.22%
Nicholas Investment Partners, LP 942,137$27,755,3562.07%
View complete list of CYTOKINETICS INC shareholders